{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:48:58Z","timestamp":1761061738426},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,27]]},"abstract":"<jats:p>Treatment of pediatric AHO requires antibiotic\/surgical management. Considerable clinical experience exists, but with current knowledge of antibiotic pharmacokinetics and pharmacodynamics, recommendations for dosages for old or new antibiotics should be based on current standards for drug development whenever possible.<\/jats:p>","DOI":"10.1093\/jpids\/piac108","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T17:06:42Z","timestamp":1665853602000},"page":"61-63","source":"Crossref","is-referenced-by-count":2,"title":["What Is the Appropriate Dose, Route, and Duration of Antibiotic Therapy for Pediatric Acute Hematogenous Osteomyelitis (AHO)? I Wish I Knew"],"prefix":"10.1093","volume":"12","author":[{"given":"John S","family":"Bradley","sequence":"first","affiliation":[{"name":"PIDS\/IDSA Guideline Writing Committee for Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics, Division of Infectious Diseases, Department of Pediatrics, University of California San Diego School of Medicine, Rady Children\u2019s Hospital San Diego , San Diego, California , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3476(78)80455-7","article-title":"Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis","volume":"92","author":"Tetzlaff","year":"1978","journal-title":"J Pediatr"},{"issue":"5","key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"e02309","DOI":"10.1128\/AAC.02309-18","article-title":"Considerations for dose selection and clinical pharmacokinetics\/pharmacodynamics for the development of antibacterial agents","volume":"63","author":"Rizk","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/INF.0000000000002790","article-title":"Daptomycin for pediatric gram-positive acute hematogenous osteomyelitis","volume":"39","author":"Bradley","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/jpids\/piab027","article-title":"Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics","volume":"10","author":"Woods","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3476(79)80049-9","article-title":"High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children","volume":"94","author":"Bryson","year":"1979","journal-title":"J Pediatr"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3476(79)80106-7","article-title":"Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis","volume":"95","author":"Prober","year":"1979","journal-title":"J Pediatr"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","article-title":"Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children","volume":"169","author":"Keren","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2023022709211971700_","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/jac\/dkaa188","article-title":"Dalbavancin for the management of osteomyelitis: a major step forward?","volume":"75","author":"Almangour","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piac108\/46539442\/piac108.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/12\/2\/61\/49342933\/piac108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/12\/2\/61\/49342933\/piac108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T10:49:45Z","timestamp":1678272585000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/12\/2\/61\/6761663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10,15]]},"published-print":{"date-parts":[[2023,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piac108","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,10,15]]}}}